• Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
  • Obstetric Panel
  • PIK3CA Gene Mutation Analysis (Therascreen PIK3CA)
  • Gastrin, Serum
  • Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Genotyping
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • B-Type Natriuretic Peptide (BNP)
  • Lead, Blood
  • Rapid Plasma Reagin (RPR), CSF
  • Creatinine, 24 Hour, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
Medical Test

Additional Testing
Access to Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq) is restricted.